Ultralife Corporation

5.46
0.05 (0.92%)
At close: Mar 27, 2025, 3:59 PM
5.47
0.18%
After-hours: Mar 27, 2025, 04:24 PM EDT

Ultralife Statistics

Share Statistics

Ultralife has 16.63M shares outstanding. The number of shares has increased by 1.1% in one year.

Shares Outstanding 16.63M
Shares Change (YoY) 1.1%
Shares Change (QoQ) 0.02%
Owned by Institutions (%) 37.74%
Shares Floating 10.12M
Failed to Deliver (FTD) Shares 51
FTD / Avg. Volume 0.1%

Short Selling Information

The latest short interest is 188.92K, so 1.14% of the outstanding shares have been sold short.

Short Interest 188.92K
Short % of Shares Out 1.14%
Short % of Float 1.87%
Short Ratio (days to cover) 3.47

Valuation Ratios

The PE ratio is 15.5 and the forward PE ratio is 8.56. Ultralife's PEG ratio is 0.

PE Ratio 15.5
Forward PE 8.56
PS Ratio 0.7
Forward PS 0.4
PB Ratio 0.89
P/FCF Ratio -179.06
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Ultralife Corporation has an Enterprise Value (EV) of 129.46M.

EV / Earnings 17.99
EV / Sales 0.82
EV / EBITDA 8.61
EV / EBIT 13.66
EV / FCF -207.81

Financial Position

The company has a current ratio of 3.8, with a Debt / Equity ratio of 0.23.

Current Ratio 3.8
Quick Ratio 2.02
Debt / Equity 0.23
Total Debt / Capitalization 18.88
Cash Flow / Debt 0.07
Interest Coverage 4.7

Financial Efficiency

Return on equity (ROE) is 0.06% and return on capital (ROIC) is 4.82%.

Return on Equity (ROE) 0.06%
Return on Assets (ROA) 0.04%
Return on Capital (ROIC) 4.82%
Revenue Per Employee $295,977.61
Profits Per Employee $13,427.24
Employee Count 536
Asset Turnover 0.89
Inventory Turnover 2.83

Taxes

Income Tax 1.95M
Effective Tax Rate 0.21

Stock Price Statistics

The stock price has increased by -39.98% in the last 52 weeks. The beta is 1.05, so Ultralife's price volatility has been higher than the market average.

Beta 1.05
52-Week Price Change -39.98%
50-Day Moving Average 6.78
200-Day Moving Average 8.66
Relative Strength Index (RSI) 32.17
Average Volume (20 Days) 51.25K

Income Statement

In the last 12 months, Ultralife had revenue of 158.64M and earned 7.2M in profits. Earnings per share was 0.44.

Revenue 158.64M
Gross Profit 39.2M
Operating Income 9.47M
Net Income 7.2M
EBITDA 15.04M
EBIT 9.47M
Earnings Per Share (EPS) 0.44
Full Income Statement

Balance Sheet

The company has 10.28M in cash and 29.16M in debt, giving a net cash position of -18.88M.

Cash & Cash Equivalents 10.28M
Total Debt 29.16M
Net Cash -18.88M
Retained Earnings -40.75M
Total Assets 172.44M
Working Capital 60.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.93M and capital expenditures -2.55M, giving a free cash flow of -623K.

Operating Cash Flow 1.93M
Capital Expenditures -2.55M
Free Cash Flow -623K
FCF Per Share -0.04
Full Cash Flow Statement

Margins

Gross margin is 24.71%, with operating and profit margins of 5.97% and 4.54%.

Gross Margin 24.71%
Operating Margin 5.97%
Pretax Margin 5.75%
Profit Margin 4.54%
EBITDA Margin 9.48%
EBIT Margin 5.97%
FCF Margin -0.39%

Dividends & Yields

ULBI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 8.12%
FCF Yield -0.69%
Dividend Details

Analyst Forecast

The average price target for ULBI is $14, which is 158.3% higher than the current price. The consensus rating is "Buy".

Price Target $14
Price Target Difference 158.3%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score 2.77
Piotroski F-Score 6